Oliver Schadt

This inventor holds 58 USPTO granted patents and 4 published patent applications, plus 26 CIPO patents and 36 EPO patents, primarily in Pyridazinone Derivatives (CPC class C07D). Top assignees: Merck Patent Gmbh, Merck Patent Gesellschaft MIT Beschrankter Haftung, Merck Patent Gesellschaft. Active years: 2003-2024.

USPTO Granted Patents = 58 (Patent Applications = 4)

% Patents Active = 41.4

CIPO Patents = 26 (Patent Applications = 7)

EPO Patents = 36 (Patent Applications = 30)

Average Co-Inventor Count = 4.3

ph-index = 8

Forward Citations = 174(Granted Patents)

Forward Citations (Not Self Cited) = 106(Dec 10, 2025)

Inventors with similar research interests:

Company Filing History:

Merck Patent Gesellschaft MIT Beschrankter Haftung

patents

1 out of 121

Merck Patent Gesellschaft

patents

4. 1 out of 100

Merck Patent Gesellschaft MIT Beschraenkter Haftung

patents

Years Active: 2003-2024

Loading Chart...

Areas of Expertise:

Pyridazinone Derivatives

Boronic Acid Derivatives

Kinase Inhibitors

Immunoproteasome Inhibitors

Pyrimidinyl Derivatives

Polymorphic Forms

Benzothiazolone Derivatives

Dihydropyrazole Derivatives

Aryl Ether Derivatives

Methylene Urea Derivatives

Thiadiazinone Derivatives

Triazole Derivatives

58 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11858951 - Boronic acid derivatives (2024-01-02),

2. 11274109 - Boronic acid derivatives (2022-03-15),

3. 10669289 - Boronic acid derivatives (2020-06-02),

4. 10640520 - Boronic acid derivatives (2020-05-05),

5. 10294246 - Substituted boronic acids and boronate esters as immunoproteasome inhibitors (2019-05-21),

6. 10253049 - Boronic acid derivatives (2019-04-09),

7. 9481668 - Quinoline inhibitor of the macrophage stimulating 1 receptor MSTR1 (2016-11-01),

8. 9403799 - Pyrimidinyl-pyridazinone derivatives for treating a disease which is influenced by inhibition of met kinase (2016-08-02),

9. 9376426 - Pyridazinone derivatives (2016-06-28),

10. 9308205 - Polymorphic forms of 3-(1-{3-[5-(1-methyl-piperidin-4-ylmethoxy)-pyrimidin-2-yl]-benzyl}-6-oxo-1,6-dihydro-pyrdazin-3-yl)-benzonitrile hydrochloride salt and processes of manufacturing thereof (2016-04-12),

11. 9289427 - Polymorphic forms of 3-(1-{3-[5-(1-methyl-piperidin-4-ylmethoxy)-pyrimidin-2-yl]-benzyl}-6-oxo-1,6-dihydro-pyridazin-3-hydrochloride salt and processes of manufacturing thereof (2016-03-22),

12. 9284300 - Pyridazinone derivatives (2016-03-15),

13. 9283225 - Pyrido-pyrimidine derivatives (2016-03-15),

14. 9221806 - 2-(heterocyclylbenzyl)pyridazinone derivatives (2015-12-29),

15. 9062029 - Pyrimidinyl pyridazinone derivatives (2015-06-23),

Title: Inventor Oliver Schadt

Introduction: Oliver Schadt is a renowned inventor hailing from Rodenbach, Germany. His innovative spirit and dedication to creating groundbreaking solutions have earned him a prominent place in the world of inventions.

Latest Patents: Oliver Schadt holds several patents in various fields, including technology, engineering, and healthcare. His recent patents focus on sustainable energy solutions and advanced medical devices.

Career Highlights: With a career spanning over two decades, Oliver Schadt has made significant contributions to the field of innovation. He has worked with leading research institutions and companies to bring his ideas to life.

Collaborations: Throughout his career, Oliver Schadt has collaborated with top engineers, scientists, and designers to develop cutting-edge products. His collaborative efforts have resulted in the creation of revolutionary technologies that have impacted industries worldwide.

Conclusion: Oliver Schadt's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors. His remarkable achievements solidify his position as a visionary in the world of inventions.